HomeCompareBOPFF vs JNJ

BOPFF vs JNJ: Dividend Comparison 2026

BOPFF yields 100000.00% · JNJ yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BOPFF wins by $4.832206901976048e+26M in total portfolio value
10 years
BOPFF
BOPFF
● Live price
100000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.832206901976048e+26M
Annual income
$482,271,988,201,431,700,000,000,000,000,000.00
Full BOPFF calculator →
JNJ
Johnson & Johnson
● Live price
2.14%
Share price
$242.49
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.5K
Annual income
$4,749.88
Full JNJ calculator →

Portfolio growth — BOPFF vs JNJ

📍 BOPFF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBOPFFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BOPFF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BOPFF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BOPFF
Annual income on $10K today (after 15% tax)
$8,500,000.00/yr
After 10yr DRIP, annual income (after tax)
$409,931,189,971,216,900,000,000,000,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$182.28/yr
After 10yr DRIP, annual income (after tax)
$4,037.40/yr
At 15% tax rate, BOPFF beats the other by $409,931,189,971,216,900,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BOPFF + JNJ for your $10,000?

BOPFF: 50%JNJ: 50%
100% JNJ50/50100% BOPFF
Portfolio after 10yr
$2.416103450988024e+26M
Annual income
$241,135,994,100,715,840,000,000,000,000,000.00/yr
Blended yield
99.80%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

BOPFF
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-5.7% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BOPFF buys
0
JNJ buys
0
No recent congressional trades found for BOPFF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBOPFFJNJ
Forward yield100000.00%2.14%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$4.832206901976048e+26M$30.5K
Annual income after 10y$482,271,988,201,431,700,000,000,000,000,000.00$4,749.88
Total dividends collected$4.8315851896727036e+26M$15.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: BOPFF vs JNJ ($10,000, DRIP)

YearBOPFF PortfolioBOPFF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,010,700$10,000,000.00$10,594$274.49+$10.00MBOPFF
2$9,366,505,842$9,355,794,392.52$11,294$360.69+$9366.49MBOPFF
3$8,191,091,111,834$8,181,068,950,583.78$12,133$476.91+$8191091.10MBOPFF
4$6,695,134,751,499,451$6,686,370,284,009,789.00$13,156$635.42+$6695134751.49MBOPFF
5$5,114,850,040,116,031,000$5,107,686,245,931,928,000.00$14,432$854.61+$5114850040116.02MBOPFF
6$3,652,290,278,277,141,000,000$3,646,817,388,734,216,400,000.00$16,056$1,162.76+$3652290278277141.00MBOPFF
7$2,437,583,176,648,375,000,000,000$2,433,675,226,050,619,000,000,000.00$18,175$1,604.53+$2437583176648375296.00MBOPFF
8$1,520,612,508,079,010,700,000,000,000$1,518,004,294,079,997,000,000,000,000.00$21,009$2,252.68+$1.5206125080790106e+21MBOPFF
9$886,637,379,601,106,600,000,000,000,000$885,010,324,217,461,900,000,000,000,000.00$24,911$3,229.73+$8.866373796011065e+23MBOPFF
10$483,220,690,197,604,800,000,000,000,000,000$482,271,988,201,431,700,000,000,000,000,000.00$30,458$4,749.88+$4.832206901976048e+26MBOPFF

BOPFF vs JNJ: Complete Analysis 2026

BOPFFStock

Border Petroleum Limited, a junior oil and gas company, engages in the acquisition, exploration, development, and production of crude oil, natural gas, and natural gas liquids in the province of Alberta, Canada. The company holds working interests in 520 gross acres in the Norris area of Central Alberta, as well as in 5 producing oil wells and 1 water disposal well; 3,170 acres in the Cherhill/Majeau area of Western Alberta; 9,805 gross acres in the Blueridge area of Northern Alberta; and 9,760 gross acres in the Mulligan area. It also holds a non-operated interest in the Chip Lake property; and operated, non-operated, and royalty interest in approximately 40 producing wells in the Maple Glen area of Alberta. The company is based in Calgary, Canada.

Full BOPFF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this BOPFF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BOPFF vs SCHDBOPFF vs JEPIBOPFF vs OBOPFF vs KOBOPFF vs MAINBOPFF vs ABBVBOPFF vs MRKBOPFF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.